Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Regression of Coronary Fatty Plaque and Risk of Cardiac Events According to Blood Pressure Status: Data From a Randomized Trial of Eicosapentaenoic Acid and Docosahexaenoic Acid in Patients With Coronary Artery Disease.
Welty FK, Hariri E, Asbeutah AA, Daher R, Amangurbanova M, Chedid G, Elajami TK, Alfaddagh A, Malik A. Welty FK, et al. Among authors: amangurbanova m. J Am Heart Assoc. 2023 Sep 19;12(18):e030071. doi: 10.1161/JAHA.123.030071. Epub 2023 Sep 8. J Am Heart Assoc. 2023. PMID: 37681568 Free PMC article. Clinical Trial.
ω-3 Ethyl ester results in better cognitive function at 12 and 30 months than control in cognitively healthy subjects with coronary artery disease: a secondary analysis of a randomized clinical trial.
Malik A, Ramadan A, Vemuri B, Siddiq W, Amangurbanova M, Ali A, Welty FK. Malik A, et al. Among authors: amangurbanova m. Am J Clin Nutr. 2021 May 8;113(5):1168-1176. doi: 10.1093/ajcn/nqaa420. Am J Clin Nutr. 2021. PMID: 33675344 Free PMC article. Clinical Trial.
Docosahexaenoic Acid Levels and Omega-3 Index, but Not Eicosapentaenoic Acid Levels, Are Associated With Improved Cognition in Cognitively Healthy Subjects With Coronary Artery Disease.
Chedid G, Malik A, Amangurbanova M, Khraishah H, Welty FK. Chedid G, et al. Among authors: amangurbanova m. Arterioscler Thromb Vasc Biol. 2023 Feb;43(2):382-384. doi: 10.1161/ATVBAHA.122.318569. Epub 2022 Dec 29. Arterioscler Thromb Vasc Biol. 2023. PMID: 36579646 Free PMC article. No abstract available.
Liver stiffness progression in biopsy-proven metabolic dysfunction-associated steatotic disease among people with diabetes versus people without diabetes: A prospective multicenter study.
Huang DQ, Wilson LA, Behling C, Amangurbanova M, Kleiner DE, Kowdley KV, Dasarathy S, Terrault NA, Diehl AM, Chalasani N, Neuschwander-Tetri BA, Sanyal AJ, Tonascia J, Loomba R; NASH Clinical Research Network. Huang DQ, et al. Among authors: amangurbanova m. Hepatology. 2024 Jul 19. doi: 10.1097/HEP.0000000000001015. Online ahead of print. Hepatology. 2024. PMID: 39028908
Repeatability of vibration-controlled transient elastography versus magnetic resonance elastography in patients with cirrhosis: A prospective study.
Siddiqi H, Huang DQ, Mittal N, Nourredin N, Bettencourt R, Madamba E, Amangurbanova M, Hernandez C, Sirlin C, Yin M, Loomba R. Siddiqi H, et al. Among authors: amangurbanova m. Aliment Pharmacol Ther. 2024 Aug;60(4):484-491. doi: 10.1111/apt.18118. Epub 2024 Jun 11. Aliment Pharmacol Ther. 2024. PMID: 38863232
20 results